EUVIMEDEUVIMED entdecken
Crossref

Optimal timing for an accelerated interim futility analysis incorporating real world data

Lillian M F Haine, Thomas A Murray, Joseph S Koopmeiners

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Lillian M F Haine und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, United States. Electronic address: haine108@umn.edu. Hauptthemen laut MEDLINE: Bayes Theorem, Medical Futility, Research Design. Die Arbeit nennt 31 Literaturangaben. Gefördert von: NCATS NIH HHS, Medtronic, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Randomized controlled trials include interim monitoring guidelines to stop early for safety, efficacy, or futility. Futility monitoring facilitates re-allocation of limited resources. However, conventional methods for interim futility monitoring require a trial to accrue nearly half of the outcome data to make a reliable early stopping decision, limiting its benefit. As early stopping for futility will not inflate type-I error, these analyses are an appealing venue for incorporating external data to improve efficiency. METHODS: We propose a Bayesian approach to futility monitoring leveraging real world data using Semi-Supervised MIXture Multi-source Exchangeability Models, which accounts for both measured and unmeasured differences between data sources. We implement futility monitoring using predictive probabilities and investigate the optimal timing with respect to the expected sample size under the null hypothesis. Because we only incorporate external data during the interim futility analysis the proposed design is not limited by type-I error inflation. RESULTS: When the external and trial data are exchangeable, the proposed method provides a roughly 70 person reduction in expected sample size under the null. Under scenarios where exchangeability does not hold, our approach still provides a 10-20 person reduction in expected sample size under the null with about 80% power. CONCLUSIONS: External data borrowing in interim futility monitoring is a promising venue to improve trial efficiency without type-I error inflation. Approaches that are acceptable to regulatory authorities and leverage the complementary strengths of real world and trial data are vital to more efficiently allocate limited resources amongst clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bayes TheoremMedical FutilityResearch DesignHumansRandomized Controlled Trials as TopicSample SizeEarly Termination of Clinical TrialsTime FactorsModels, Statistical

Stichwörter der Autor:innen

Bayesian adaptive designInterim futility monitoringRandomized controlled trialReal world data

Autor:innen und Institutionen

  • Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, United States. Electronic address: haine108@umn.edu.
  • Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, United States.

Förderung

  • NCATS NIH HHS
  • Medtronic
  • National Center for Advancing Translational Sciences
  • University of Minnesota
  • National Institutes of Health
  • Minnesota Supercomputing Institute, University of Minnesota

Zitieren

APA

Haine, L. M. F., Murray, T. A., & Koopmeiners, J. S. (2024). Optimal timing for an accelerated interim futility analysis incorporating real world data. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107489

Vancouver

Haine LMF, Murray TA, Koopmeiners JS. Optimal timing for an accelerated interim futility analysis incorporating real world data. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107489

BibTeX
@article{Haine2024,
  author = {Haine, Lillian M F and Murray, Thomas A and Koopmeiners, Joseph S},
  title = {Optimal timing for an accelerated interim futility analysis incorporating real world data},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107489}
}
Kostenlos starten →